Gamma radiation preparation of chitosan nanoparticles for controlled delivery of memantine
- 26 November 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (8) , 1150-1162
Abstract
The purpose of the current study is to prepare chitosan nanoparticles by gamma radiation as a new brain delivery system for memantine to improve its therapeutic efficiency. Fourier-transform infrared analysis of chitosan nanoparticles showed the characteristic peaks of chitosan and the reduction of particle size induced by irradiation at doses 10, 20 and 30 kGy. The solubility of chitosan nanoparticles was tested using different solvents and exhibited good solubility in both water and 1% acetic acid than other tested solvents at 80°C. Different formulations containing memantine-loaded chitosan nanoparticles were evaluated for brain targeting on aluminum-induced Alzheimer’s disease in rats. Memory deficit was evaluated using the Morris water maze test. The levels of amyloid-β peptide, tumour necrosis factor alpha, interleukin-1β and interleukin-6 in brain tissues as well as the serum level of brain-derived neurotrophic factor were assayed. Data demonstrated that memantine-loaded chitosan nanoparticles 1:1 transported memantine effectively into the brain compared to free memantine as evidenced by better behaviour performance and biochemical amelioration and confirmed by histopathological examination in Alzheimer’s disease rats. Interestingly, the therapeutic effect of memantine-loaded chitosan nanoparticles 1:1 was superior to memantine-loaded chitosan nanoparticles 1:2 and memantine-loaded chitosan nanoparticles 2:1. Based on these findings, it is reasonable to suggest that memantine-loaded chitosan nanoparticles 1:1 could be a promising approach for Alzheimer’s disease.Keywords
This publication has 39 references indexed in Scilit:
- Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndromeBehavioural Brain Research, 2011
- Neurotherapeutic applications of nanoparticles in Alzheimer's diseaseJournal of Controlled Release, 2011
- Radiation-induced degradation of chitosan for possible use as a growth promoter in agricultural purposesCarbohydrate Polymers, 2010
- Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic MiceThe American Journal of Pathology, 2010
- APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer’s diseaseJournal of Inorganic Biochemistry, 2009
- Treatment of Alzheimer’s disease in the long-term-care settingAmerican Journal of Health-System Pharmacy, 2009
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generationJournal of Neuroinflammation, 2008
- Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal CordThe Journal of Neuroscience, 2008
- Blood–brain barrier deliveryDrug Discovery Today, 2007
- Place navigation impaired in rats with hippocampal lesionsNature, 1982